SALK 新闻

萨尔克生物学研究所 - 萨尔克新闻

索尔克新闻


Salk Professor Samuel Pfaff named 2021 AAAS Fellow

拉霍亚—索尔克教授 Samuel Pfaff has been named a 2021 Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the journal 科学. Pfaff is among 564 new AAAS Fellows spanning 24 scientific disciplines who were nominated by their peers for their distinguished efforts to advance science.


Active ingredient in cannabis protects aging brain cells

LA JOLLA—Decades of research on medical cannabis has focused on the compounds THC and CBD in clinical applications. But less is known about the therapeutic properties of cannabinol (CBN). Now, a new study by Salk scientists shows how CBN can protect nerve cells from oxidative damage, a major pathway to cell death. The findings, published online January 6, 2022, in the journal Free Radical Biology and Medicine, suggest CBN has the potential for treating age-related neurodegenerative diseases, like Alzheimer’s.


Salk appoints Julie A. Auger executive director of Research Operations

LA JOLLA—The Salk Institute announced today the appointment of Julie A. Auger to the position of executive director of Research Operations. Auger will oversee all shared scientific resources at the Institute in her new role, including the scientific technology cores, animal research and shared scientific resources. The position reports to the Chief Science Officer for the Institute.


Salk Institute announces departure of Professor Juan Carlos Izpisua Belmonte

LA JOLLA—The Salk Institute announced today that Professor 胡安·卡洛斯·伊兹皮苏亚·贝尔蒙特, a world-renowned researcher who has pioneered innovations in developmental biology, regenerative medicine and aging research at the Salk Institute, will be closing his Salk laboratory to join Altos Labs, a newly created life sciences company centered on human health research. Izpisua Belmonte, who has been at Salk for nearly thirty years, will depart to lead the San Diego division of Altos Institutes of Science to study cellular rejuvenation programming with the goal of improving human health.


Plants rely on the CLASSY gene family to diversify their epigenomes

LA JOLLA—What determines how a cell’s genome is regulated to ensure proper growth and development? Turns out, the parts of the genome that are turned on or off in each cell-type or tissue play a major role in this process. Now, a team at Salk has shown that the CLASSY gene family regulates which parts of the genome are turned off in a tissue-specific manner. The CLASSYs essentially control where the genome is marked by DNA methylation—the addition of methyl chemical groups to the DNA that act like tags saying, “turn off.” Because DNA methylation exists across diverse organisms, including plants and animals, this research has broad implications for both agriculture and medicine. The work, published in Nature Communications on January 11, 2022, identifies the CLSY genes as major factors underlying epigenetic diversity in plant tissues.


Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes

拉霍亚—教授 罗纳德·埃文斯 will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine a molecular pathway that regulates blood sugar and fat independent of insulin. The research will advance our understanding of type 2 diabetes and could lead to the development of new therapies for treating the disease. Other members of the team include Professors Jin Zhang and Alan Saltiel from the University of California San Diego.


Salk researchers find a new route for regulating blood sugar levels independent of insulin

LA JOLLA—The discovery of insulin 100 years ago opened a door that would lead to life and hope for millions of people with diabetes. Ever since then, insulin, produced in the pancreas, has been considered the primary means of treating conditions characterized by high blood sugar (glucose), such as diabetes. Now, Salk scientists have discovered a second molecule, produced in fat tissue, that, like insulin, also potently and rapidly regulates blood glucose. Their finding could lead to the development of new therapies for treating diabetes, and also lays the foundation for promising new avenues in metabolism research.


San Diego Nathan Shock Center announces pilot grant awardees

LA JOLLA—The San Diego Nathan Shock Center (SD-NSC) of Excellence in the Basic Biology of Aging, a consortium between the Salk Institute for Biological Studies, Sanford Burnham Prebys (SBP) and the University of California San Diego, has announced its second-year class of pilot grant awardees. Recipients from six different institutions will receive up to $15,000 to pursue research that advances our understanding of how humans age, with the ultimate goal of extending health span, the number of years of healthy, disease-free life.


索尔克科学家荣获2021年ASPIRE奖以研究胰腺癌

拉霍亚—教授 罗纳德·埃文斯 助理教授 丹妮尔·恩格尔 已获得2021年ASPIRE(加速科学平台与创新研究)奖,用于研究胰腺癌的细胞和分子驱动因素。胰腺癌是最致命的癌症之一,治疗选择很少。$250,000美元的奖金由Mark癌症研究所基金会资助,该基金会支持旨在解决癌症研究中影响深远问题的创新方法。入选2021年ASPIRE项目的23位科学家代表了世界顶尖学术机构癌症研究领域的各个学科。.


疼痛和焦虑从细胞层面影响呼吸

LA JOLLA—You’re startled by a threatening sound, and your breath quickens; you smash your elbow and pant in pain. Why a person’s breathing rate increases dramatically when they’re hurting or anxious was not previously understood. Now, a team of Salk scientists has uncovered a neural network in the brain that coordinates breathing rhythm with feelings of pain and fear. Along with contributions to the fields of pain management, psychological theories of anxiety, and philosophical investigations into the nature of pain, their findings could lead to development of an analgesic that would prevent opioid-induced respiratory depression (OIRD), the disrupted breathing that causes overdose deaths.


改进结直肠癌患者的药物选择

LA JOLLA—Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations that are believed to cause resistance to these drugs.


Which side is which?: How the brain perceives borders

LA JOLLA—In the classic “Rubin’s vase” optical illusion, you can see either an elaborate, curvy vase or two faces, noses nearly touching. At any given moment, which scene you perceive depends on whether your brain is viewing the central vase shape to be the foreground or background of the picture.


Reading the mind of a worm

LA JOLLA—It sounds like a party trick: scientists can now look at the brain activity of a tiny worm and tell you which chemical the animal smelled a few seconds before. But the findings of a new study, led by Salk Associate Professor 斯里坎特·查拉萨尼, are more than just a novelty; they help the scientists better understand how the brain functions and integrates information.


Six Salk professors named among most highly cited researchers in the world

LA JOLLA—Salk Professors 乔安·乔里, 约瑟夫·埃克尔, 鲁斯蒂·盖奇, 萨奇达南达·潘达, 鲁本-肖凯泰 have been named to the Highly Cited Researchers list by Clarivate. The list identifies researchers who demonstrate “significant influence in their chosen field or fields through the publication of multiple highly cited papers.” Chory, Ecker and Gage have been named to this list every year since 2014, when the regular annual rankings began. This is Tye’s fifth, Shaw’s third and Panda’s first time receiving the designation. Additionally, Ecker appeared in two separate categories: “plant and animal science” and “molecular biology and genetics” and is one of 3.4 percent of researchers selected in two fields. Joseph Nery, a research assistant II in the Ecker lab, was also included on the list.


Salk Institute announces historic $100M challenge gift from Irwin and Joan Jacobs

LA JOLLA—The Salk Institute announced today that Irwin and Joan Jacobs, longtime supporters of the renowned scientific research organization, have pledged $100M to launch Salk’s five-year, $500M philanthropic and scientific Campaign for the Future. The gift is structured as a challenge match, adding $1 to every $2 pledged, as a donor naming or endowment gift. The Campaign for the Future will provide funds to construct the Joan and Irwin Jacobs Science and Technology Center on Salk’s iconic campus in La Jolla, support key scientific programs, and increase Salk’s endowment.


Salk Institute awards Medal for Research Excellence to neurobiologist and geneticist Cori Bargmann

LA JOLLA—The Salk Institute has awarded neurobiologist and geneticist Cori Bargmann its prestigious Medal for Research Excellence, which recognizes a scientist who has made significant contributions in the area of basic scientific research. Bargmann, who leads the science program at the Chan Zuckerberg Initiative (CZI) and is the Torsten N. Wiesel Professor at The Rockefeller University, received her award on November 11, 2021.


Study shines a light into “black holes” in the Arabidopsis genome

LA JOLLA—Salk scientists, collaborating with researchers from the University of Cambridge and Johns Hopkins University, have sequenced the genome of the world’s most widely used model plant species, Arabidopsis thaliana, at a level of detail never previously achieved. The study, published in 科学 on November 12, 2021, reveals the secrets of 拟南芥 chromosome regions called centromeres. The findings shed light on centromere evolution and provides insights into the genomic equivalent of black holes.


Secrets of quillwort photosynthesis could boost crop efficiency

LA JOLLA—The humble quillworts are an ancient group of about 250 small, aquatic plants that have largely been ignored by modern botanists. Now, Salk scientists, along with researchers from the Boyce Thompson Institute, have sequenced the first quillwort genome and uncovered some secrets of the plant’s unique method of photosynthesis—secrets that could eventually lead to the engineering of crops with more efficient water use and carbon capture to address climate change. The findings were published in Nature Communications on November 3, 2021.


Uncovering how injury to the pancreas impacts cancer formation

LA JOLLA—Scientists at the Salk Institute and Vanderbilt University School of Medicine Basic Sciences have found that cells in the pancreas form new cell types to mitigate injury, but are then susceptible to cancerous mutations. The research, led by Salk Professor Geoffrey Wahl and Vanderbilt Assistant Professor Kathy DelGiorno, former staff scientist in the Wahl lab, was published in the journal Gastroenterology on October 22, 2021.


Salk Professor Tatyana Sharpee receives ASBMB DeLano Award

拉霍亚—索尔克教授 塔季扬娜·沙尔佩 has won the American Society for Biochemistry and Molecular Biology’s (ASBMB) 2022 DeLano Award for Computational Biosciences. The award is given to a scientist with an innovative development or application of a computer technology that can enhance research in the life sciences at the molecular level.